Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 34 holding rows worth $84,048,298.

Accession
0001931118-25-000004
Filer
CIK 1931118
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 34 entries on the cover page, a total value of $84,048,298 stated on the cover page (in dollars after the unit check, H1), rows summing to $84,048,298 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZAI LAB LTD ADR98887Q104ADR294,947$10,659,385dollars as filed
BRIDGEBIO PHARMA INC10806X102COM183,922$6,358,184dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS96,821$6,147,165dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS160,442$5,443,797dollars as filed
Pfizer Inc.717081103COM196,164$4,970,796dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK423,632$4,685,370dollars as filed
COGENT BIOSCIENCES INC19240Q201COM774,721$4,640,579dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM819,194$4,571,103dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM237,487$4,255,767dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock1,357,153$3,745,742dollars as filed
CYTOKINETICS INC23282W605COM NEW72,992$2,933,548dollars as filed
SAVARA INC805111101COM966,203$2,676,382dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM132,019$2,546,647dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM54,216$2,392,552dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK241,192$2,288,912dollars as filed
VERASTEM INC92337C203COMMON STOCK336,363$2,028,269dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK360,000$1,533,600dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock43,613$1,462,780dollars as filed
SOLENO THERAPEUTICS INC834203309COM19,332$1,381,271dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock3,815$1,263,642dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock32,145$1,255,905dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK755,599$1,050,283dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK50,746$898,712dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock111,605$881,680dollars as filed
89BIO INC282559103COM109,156$793,564dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock22,271$657,440dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK458,972$635,676dollars as filed
VAXCYTE INC COM92243G108Stock11,264$425,329dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK191,287$369,184dollars as filed
OCULAR THERAPEUTIX INC67576A100COM42,297$310,037dollars as filed
SCHRODINGER INC COM80810D103Stock14,114$278,610dollars as filed
CENTURY THERAPEUTICS INC15673T100COM462,963$220,370dollars as filed
CUMBERLAND PHARMACEUTICALS I230770109COM50,000$211,500dollars as filedcall
LAKESHORE BIOPHARMA CO LTDG9845F208COM30,792$74,517dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-25-000004this filing2025-05-15acceptance time not in the bulk data set